Abstract
Primary generalized glucocorticoid resistance or Chrousos syndrome is a rare disorder, which affects all tissues expressing the human glucocorticoid receptor. It is characterized by generalized, partial tissue insensitivity to glucocorticoids caused by genetic defects in the NR3C1 gene. We and others have applied standard methods of molecular and structural biology to investigate the molecular mechanisms and conformational alterations through which the mutant glucocorticoid receptors lead to the broad spectrum of clinical manifestations of Chrousos syndrome. The ever-increasing application of novel technologies, including the next-generation sequencing, will enhance our knowledge in factors that influence the glucocorticoid signal transduction in a positive or negative fashion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACTH:
-
Adrenocorticotropic hormone
- AP-1:
-
Activator protein-1
- AVP:
-
Arginine vasopressin
- CpG:
-
Cytosine-guanine dinucleotides
- CRH:
-
Corticotropin-releasing hormone
- DHEA:
-
Dehydroepiandrosterone
- DHEAS:
-
Dehydroepiandrosterone-sulfate
- GR:
-
Glucocorticoid receptor
- GREs:
-
Glucocorticoid response elements
- GRIP1:
-
Glucocorticoid receptor-interacting protein 1
- GST:
-
Glutathione-S-transferase
- hGR:
-
Human glucocorticoid receptor
- hGRα:
-
Human glucocorticoid receptor alpha
- hGRβ:
-
Human glucocorticoid receptor beta
- HPA axis:
-
Hypothalamic-pituitary-adrenal axis
- HSP:
-
Heat-shock proteins
- LBD:
-
Ligand-binding domain
- MAPK:
-
Mitogen-activated protein kinase
- NF-κB:
-
Nuclear factor-κB
- PGGR:
-
Primary generalized glucocorticoid resistance
- PI3K:
-
Phosphatidylinositol 3-kinase
- STATs:
-
Signal transducers and activators of transcription
- UFC:
-
Urinary free cortisol
References
Al Argan R, Saskin A, Yang JW, D'Agostino MD, Rivera J (2018) Glucocorticoid resistance syndrome caused by a novel NR3C1 point mutation. Endocr J 65(11):1139–1146
Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995) Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435–2441
Beger C, Gerdes K, Lauten M et al (2003) Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 122(2):245–252
Bouligand J, Delemer B, Hecart AC et al (2010) Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess. PLoS One 5:e13563
Charmandari E (2011) Primary generalized glucocorticoid resistance and hypersensitivity. Horm Res Paediatr 76:145–155
Charmandari E (2012) Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response. Sci Signal 5:pt5
Charmandari E, Kino T (2010) Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signaling changes. Eur J Clin Investig 40:932–942
Charmandari E, Kino T, Vottero A, Souvatzoglou E, Bhattacharyya N, Chrousos GP (2004) Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission and clinical phenotype. J Clin Endocrinol Metab 89(4):1939–1949
Charmandari E, Chrousos GP, Ichijo T et al (2005a) The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes. Mol Endocrinol 19:52–64
Charmandari E, Raji A, Kino T et al (2005b) A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 90:3696–3705
Charmandari E, Tsigos C, Chrousos GP (2005c) Endocrinology of the stress response. Annu Rev Physiol 67:259–284
Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP (2006) Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance. J Clin Endocrinol Metab 91:1535–1543
Charmandari E, Kino T, Ichijo T et al (2007) A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 92:3986–3990
Charmandari E, Kino T, Ichijo T, Chrousos GP (2008) Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 93:1563–1572
Charmandari E, Kino T, Chrousos GP (2013) Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev 24:67–85
Chrousos G (2011) Q&A: primary generalized glucocorticoid resistance. BMC Med 9:27
Chrousos GP, Kino T (2005) Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005(304):pe48
Chrousos GP, Vingerhoeds A, Brandon D et al (1982) Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 69:1261–1269
Demonacos C, Djordjevic-Markovic R, Tsawdaroglou N, Sekeris CE (1995) The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. J Steroid Biochem Mol Biol 55(1):43–55
Deng Q, Waxse B, Riquelme D, Zhang J, Aguilera G (2015) Helix 8 of the ligand binding domain of the glucocorticoid receptor (GR) is essential for ligand binding. Mol Cell Endocrinol 408:23–32
Dobson MG, Redfern CP, Unwin N, Weaver JU (2001) The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab 86(5):2270–2274
Galon J, Franchimont D, Hiroi N et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16(1):61–71
Gossain VV, El-Rifai M, Krishnan P, Bhavsar B (2018) Cushing’s syndrome with no clinical stigmata - a variant of glucocorticoid resistance syndrome. Clin Diabetes Endocrinol 4:23
Grad I, Picard D (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrinol 275(1–2):2–12
Groeneweg FL, Karst H, de Kloet ER, Joëls M (2012) Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol 350(2):299–309
Huizenga NA, Koper JW, De Lange P et al (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83(1):144–151
Hurley DM, Accili D, Stratakis CA et al (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87:680–686
Karl M, Lamberts SW, Detera-Wadleigh SD et al (1993) Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab 76:683–689
Karl M, Lamberts SW, Koper JW et al (1996) Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296–307
Kino T (2018) Single nucleotide variations of the human GR gene manifested as pathologic mutations or polymorphisms. Endocrinology 159(7):2506–2519
Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP (2001) Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 86:5600–5608
Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST (1995) A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 55(13):2727–2729
Lee SR, Kim HK, Song IS et al (2013) Glucocorticoids and their receptors: insights into specific roles in mitochondria. Prog Biophys Mol Biol 112(1–2):44–54
Lin RC, Wang XL, Dalziel B et al (2003a) Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes Res 11(6):802–808
Lin RC, Wang XL, Morris BJ (2003b) Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41(3):404–407
Lu NZ, Cidlowski JA (2005) Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:331–342
Lu NZ, Collins JB, Grissom SF, Cidlowski JA (2007) Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol 27(20):7143–7160
Malchoff DM, Brufsky A, Reardon G et al (1993) A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 91:1918–1925
Manenschijn L, van den Akker EL, Lamberts SW, van Rossum EF (2009) Clinical features associated with glucocorticoid receptor polymorphisms an overview. Ann N Y Acad Sci 1179(1):179–198
Marti A, Ochoa MC, Sánchez-Villegas A et al (2006) Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity. BMC Med Genet 7(1):50
McBeth L, Nwaneri AC, Grabnar M, Demeter J, Nestor-Kalinoski A, Hinds TD Jr (2016) Glucocorticoid receptor beta increases migration of human bladder cancer cells. Oncotarget 7(19):27313–27324
McMahon SK, Pretorius CJ, Ungerer JP et al (2010) Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 95:297–302
Mendonca BB, Leite MV, de Castro M et al (2002) Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. J Clin Endocrinol Metab 87:1805–1809
Molnár Á, Patócs A, Likó I, Nyírő G, Rácz K, Tóth M, Sármán B (2018) An unexpected, mild phenotype of glucocorticoid resistance associated with glucocorticoid receptor gene mutation case report and review of the literature. BMC Med Genet 19(1):37
Nader N, Bachrach BE, Hurt DE et al (2010) A novel point mutation in the helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. J Clin Endocrinol Metab 95:2281–2285
Nicolaides NC, Charmandari E (2017) Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes. Hormones (Athens) 16(2):124–138
Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E (2010) The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75:1–12
Nicolaides NC, Charmandari E, Chrousos GP, Kino T (2014a) Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. BMC Endocr Disord 14:71
Nicolaides NC, Roberts ML, Kino T et al (2014b) A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities. J Clin Endocrinol Metab 99:E902–E907
Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E (2015a) Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation 22:6–19
Nicolaides NC, Geer EB, Vlachakis D et al (2015b) A novel mutation of the hGR gene causing Chrousos syndrome. Eur J Clin Investig 45:782–791
Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E (2016a) Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance. Hormones (Athens) 15(1):23–34
Nicolaides NC, Skyrla E, Vlachakis D et al (2016b) Functional characterization of the hGRαT556I causing Chrousos syndrome. Eur J Clin Investig 46(1):42–49
Nicolaides NC, Kino T, Roberts ML et al (2017) The role of S-Palmitoylation of the human glucocorticoid receptor (hGR) in mediating the nongenomic glucocorticoid actions. J Mol Biochem 6(1):3–12
Oakley RH, Cidlowski JA (2011) Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J Biol Chem 286:3177–3184
Quax RA, Manenschijn L, Koper JW et al (2013) Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol 9(11):670–686
Ramamoorthy S, Cidlowski JA (2016) Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin N Am 42(1):15–31
Ray DW, Davis JR, White A, Clark AJ (1996) Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res 56(14):3276–3280
Rhen T, Cidlowski JA (2005) Anti-inflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med 353(16):1711–1723
Roberts ML, Kino T, Nicolaides NC et al (2013) A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. J Clin Endocrinol Metab 98:E790–E795
Ruiz M, Lind U, Gafvels M et al (2001) Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol 55:363–371
Samarasinghe RA, Witchell SF, DeFranco DB (2012) Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling. Cell Cycle 11(15):2819–2827
Stechschulte LA, Wuescher L, Marino JS, Hill JW, Eng C, Hinds TD Jr (2014) Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN. J Biol Chem 289:17885–17894
van Moorsel D, van Greevenbroek MM, Schaper NC et al (2015) BclI glucocorticoid receptor polymorphism in relation to cardiovascular variables: the Hoorn and CODAM studies. Eur J Endocrinol 173(4):455–464
van Rossum EF, Lamberts SW (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59:333–357
van Rossum EF, Koper JW, Huizenga NA et al (2002) A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51(10):3128–3134
van Rossum EF, Koper JW, van den Beld AW et al (2003) Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol 59(5):585–592
van Rossum EF, Voorhoeve PG, te Velde SJ et al (2004) The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J Clin Endocrinol Metab 89(8):4004–4009
Velayos T, Grau G, Rica I, Pérez-Nanclares G, Gaztambide S (2016) Glucocorticoid resistance syndrome caused by two novel mutations in the NR3C1 gene. Endocrinol Nutr 63(7):369–371
Vitellius G, Fagart J, Delemer B et al (2016) Three novel heterozygous point mutations of NR3C1 causing glucocorticoid resistance. Hum Mutat 37(8):794–803
Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP (2002) A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87:2658–2667
Wang Q, Lu PH, Shi ZF et al (2015) Glucocorticoid receptor β acts as a co-activator of T-cell factor 4 and enhances glioma cell proliferation. Mol Neurobiol 52(3):1106–1118
Wu I, Shin SC, Cao Y et al (2013) Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis 4:e453
Yin Y, Zhang X, Li Z et al (2013) Glucocorticoid receptor β regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of β-catenin/TCF transcriptional activity. Neurobiol Dis 59:165–176
Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA (2003) Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 23:4319–4330
Zannas AS, Chrousos GP (2017) Epigenetic programming by stress and glucocorticoids along the human lifespan. Mol Psychiatry 22(5):640–646
Zhu HJ, Dai YF, Wang O et al (2011) Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene. Chin Med J 124:551–555
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nicolaides, N.C., Charmandari, E. (2019). Glucocorticoid Resistance. In: Igaz, P., Patócs, A. (eds) Genetics of Endocrine Diseases and Syndromes. Experientia Supplementum, vol 111. Springer, Cham. https://doi.org/10.1007/978-3-030-25905-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-25905-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25904-4
Online ISBN: 978-3-030-25905-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)